ST-501

N/A

Report date: 2024/03/04 16:09:53

Base Information

Drug NameST-501
Drug Alias NameST-501ST501
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGenetic transcription inhibitorsMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsTauopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSangamo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiogen IncSangamo Therapeutics IncGenentech Inc
Inactive CompaniesN/A
Active IndicationsTauopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A